

Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ASXC | NYSE | USD | Real-time | |
ASXC | NYSE Amex | USD | Delayed | |
2TX | Frankfurt | EUR | Delayed |
Axsome Therapeutics (NASDAQ:AXSM) +20% on raising $23.3M (NYSE:MMM) under existing ATM facility.Pyxis Tankers (NASDAQ:PXS) +13%.Taoping (NASDAQ:TAOP) +11% to acquire 51% of Shenzhen Taoping New Media...
TransEnterix (NYSEMKT:TRXC) is off 9% premarket on light volume on the heels of its $75M at-the-market stock sales agreement with Stifel.Stifel will earn a 3% commission for its efforts.Now read:...
DCIX +69% on Q1 result. QUMU +22% on receiving $1M in cloud license fees. TRIP +18% on Q1 result. AAXN +12% on Q1 result. TRXC +11% on Q1 result. EPE +11% on Q1 result. FTFT...
Amneal Pharmaceuticals (NYSE:AMRX) initiated with Buy rating and $26 (77% upside) price target at Deutsche Bank (DE:DBKGn).Arrowhead Pharmaceuticals (NASDAQ:ARWR) upgraded to Overweight with a $13...
CVNA -14% on Q4 earnings.DLTR -12% on Q4 earnings.TRXC -10% on Q4 earnings.TTOO -7% on Q4 earnings.BZUN -5% on Q4 earnings. Now read: After Hours Gainers / Losers (3/6/2018)Original article
TransEnterix (NYSEMKT:TRXC) is up 8% premarket on average volume in response to its announcement that it has filed a 510(k) application with the FDA seeking clearance to use its Senhance Surgical...
By Manas Mishra (Reuters) - Intuitive Surgical Inc (O:ISRG) said on Thursday it would continue to spend heavily on research and development in 2018, seeking to fend off competition and maintain its...
Gainers: LENS +136%. PFNX +55%. CERC +18%. RIOT +16%. CANF +15%.Losers: NVAX -18%. ICCC -16%. EYES -8%. TRXC -7%. BLPH -7%.Now read: Concert Pharma (CNCE) Presents At Jefferies 2017 London Healthcare...
JCP -25% on lowering outlook.EFII -21% on Q3 earnings.SRAX -13% on announcing private placement of $5.18M with existing shareholders.EXPE -16% on Q3 earnings.MAT -15% on Q3 earnings.VSAR -11% on Q3...
SSKN +38% on deal with aesthetic medical market-focused group purchasing organization. SPPI +34% as poziotinib shows encouraging effect in treatment-resistant lung cancer patients in mid-stage...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review